Baillie Gifford & Co. Buys 315,763 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• Baillie Gifford & Co. increased its stake in Healthpeak by 613.2% in Q4, buying 315,763 shares to hold 367,256 shares (about 0.05% of the company) valued at roughly $5.905 million.
• Healthpeak beat Q4 estimates with $0.47 EPS (vs. $0.45) and $719.4M revenue (vs. $685.1M), set FY2026 guidance of $1.700–1.740 EPS, while analysts project about $1.86 EPS for the year.
• The company announced a monthly dividend of $0.1017 payable June 26, implying a 7.2% yield, though the reported payout ratio is an unusually high 1,220%.

Baillie Gifford & Co. increased its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 613.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 367,256 shares of the real estate investment trust's stock after purchasing an additional 315,763 shares during the period. Baillie Gifford & Co. owned approximately 0.05% of Healthpeak Properties worth $5,905,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Mather Group LLC. bought a new position in shares of Healthpeak Properties in the third quarter worth $25,000. City Holding Co. bought a new position in shares of Healthpeak Properties in the third quarter worth $26,000. Rexford Capital Inc. bought a new position in shares of Healthpeak Properties in the second quarter worth $28,000. Sound Income Strategies LLC bought a new position in shares of Healthpeak Properties in the third quarter worth $28,000. Finally, CYBER HORNET ETFs LLC bought a new position in shares of Healthpeak Properties in the second quarter worth $33,000. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $16.88 on Wednesday. The business's 50-day moving average price is $17.01 and its 200-day moving average price is $17.34. Healthpeak Properties, Inc. has a 12 month low of $15.71 and a 12 month high of $19.68. The firm has a market capitalization of $11.74 billion, a price-to-earnings ratio of 168.82, a PEG ratio of 8.83 and a beta of 1.10. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The business's revenue for the quarter was up 3.1% on a year-over-year basis. During the same period last year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be paid a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 7.2%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties's payout ratio is currently 1,220.00%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Argus cut Healthpeak Properties from a "buy" rating to a "hold" rating in a research report on Thursday, February 5th. Wells Fargo & Company reiterated a "positive" rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Evercore decreased their target price on Healthpeak Properties from $21.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 4th. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research report on Monday, January 5th. Finally, Citigroup decreased their target price on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating on the stock in a research report on Wednesday, April 1st. Six equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Healthpeak Properties currently has an average rating of "Hold" and a consensus target price of $19.19.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.